A novel intravitreal axitinib hydrogel demonstrated durable disease control in patients with treatment-naive neovascular age-related macular degeneration (AMD), with superior maintenance of visual ...

A single injection of sura-vec reduced the severity of nonproliferative diabetic retinopathy for up to 2 years, according to ...

Anti-VEGF injection followed by dexamethasone intravitreal implant showed noninferior efficacy to conventional treatment regimen.

For decades, the management of diabetic retinopathy (DR) has consisted mainly of optimizing metabolic control (blood glucose, pressure and lipids) and routine surveillance as preventive strategies, ...

Samsung Bioepis Co., Ltd. today announced the relaunch of BYOOVIZ ® (ranibizumab-nuna) in the United States (US), in partnership with Harrow (Nasdaq: HROW). Harrow became responsible for ...

Detailed price information for Theriva Biologics Inc (TOVX-A) from The Globe and Mail including charting and trades.

Director Francesco Calabrò of the Ophthalmology Unit at Azienda Ospedaliera dei Colli, together with his team nurses Angela ...

Practicing ophthalmologists have an amazing legacy of catalyzing innovation to enhance our ability to retain, restore and ...

FRONT-2 global enrollment completed approximately 4 months ahead of initial projections4FRONT-2 over-enrolled (anticipated N>500), with final ...

Expands Harrow's Growing Retina Portfolio with an Interchangeable Ranibizumab BiosimilarNASHVILLE, Tenn., July 01, 2026 ...